High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas

Autor: M-T Chaumette, François Berrehar, Antoine Charachon, Mehdi Karoui, S. Bastuji-Garin, J-P Farcet, S. Le Gouvello, Iradj Sobhani, A Seikour, Karen Leroy, Hicham Mansour, Nijez Aloulou
Přispěvatelé: Institut Mondor de recherche biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service d'immunologie biologique, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service d'hépato-gastro-entérologie [APHP Henri Mondor], Département de pathologie [Mondor], Service de chirurgie digestive, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor, Supported by grants from DRCD Assistance Publique – Hôpitaux de Paris, Ligue contre le cancer, ACD., Guellaen, Georges
Jazyk: angličtina
Rok vydání: 2008
Předmět:
Male
Pathology
medicine.medical_specialty
CD3 Complex
Colorectal cancer
Colon
DNA Mismatch Repair
03 medical and health sciences
0302 clinical medicine
[SDV.BBM] Life Sciences [q-bio]/Biochemistry
Molecular Biology

medicine
Biomarkers
Tumor

Cytotoxic T cell
Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

Intestinal Mucosa
Immunity
Mucosal

MSI
030304 developmental biology
Aged
Neoplasm Staging
Retrospective Studies
0303 health sciences
IL-6
biology
business.industry
Reverse Transcriptase Polymerase Chain Reaction
Interleukin-17
Gastroenterology
FOXP3
Microsatellite instability
Cancer
Forkhead Transcription Factors
medicine.disease
digestive system diseases
3. Good health
Granzyme B
IL-17
Phenotype
Perforin
colon cancer
030220 oncology & carcinogenesis
Foxp3
biology.protein
Cancer research
Immunohistochemistry
Female
business
Colorectal Neoplasms
Zdroj: Gut
Gut, BMJ Publishing Group, 2008, 57 (6), pp.772-9. ⟨10.1136/gut.2007.123794⟩
ISSN: 0017-5749
1468-3288
Popis: International audience; BACKGROUND AND AIMS: Colorectal cancer (CRC) harbours different types of DNA alterations, including microsatellite instability (MSI). Cancers with high levels of MSI (MSI-H) are considered to have a good prognosis, probably related to lymphocyte infiltration within tumours. The aim of the present study was to characterise the intratumoural expression of markers associated with the antitumour immune response in mismatch repair (MMR)-proficient (MSS) colon cancers. METHODS: Ninety human colon cancers (T) and autologous normal colon mucosa (NT) were quantified for the expression of 15 markers of the immune response with quantitiative reverse transcription-PCR (qRT-PCR). mRNA expression levels were correlated with MMR status. Immunohistochemistry (IHC) was performed using both interleukin 17 (IL17) and CD3 antibodies. RESULTS: Expression of cytotoxic markers (FasL, granzyme B and perforin), inflammatory cytokines (IL1beta, IL6, IL8, IL17 and transforming growth factor beta (TGFbeta)) and a marker of regulatory T cells (forkhead box P3 (Foxp3)) was significantly higher in tumours than in autologous normal tissues. Adjusting for MMR status, higher tumoural expression of both granzyme B and perforin was associated with the MSI-H phenotype, and the perforin T/NT ratio was higher in MSI-H tissues than in MSS tissues. Higher tumoural expression of Foxp3, IL17, IL1beta, IL6 and TGFbeta was associated with the MSS phenotype, and the IL17 T/NT ratio was higher in MSS tissues than in MSI-H tissues as assessed by both qRT-PCR and IHC. CONCLUSIONS: Immune gene expression profiling in CRC displayed different patterns according to MMR status. Higher Foxp3, IL6, TGFbeta and IL17 expression is a particular determinant in MMR-proficient CRC. These may be potential biomarkers for a new prognostic "test set" in sporadic CRCs.
Databáze: OpenAIRE